RSS-Feed abonnieren

DOI: 10.1055/s-0045-1813653
Doctors' Perceptions of Artificial Intelligence in Managing Diabetes during Ramadan: An Exploratory Cross-Sectional Survey
Autor*innen
Funding and Sponsorship None.
Abstract
Background
Ramadan fasting (RF) presents unique challenges for people with diabetes. Artificial intelligence (AI) has the potential to enhance safety and personalize care, but little is known about doctors' readiness to adopt such tool in this context.
Objectives
This article explores doctors' knowledge, attitudes, and practices regarding the use of AI in managing diabetes during Ramadan.
Materials and Methods
An online exploratory cross-sectional survey of a convenience sample of 134 doctors was conducted between July 18 and August 31, 2025, using a structured questionnaire distributed through professional networks interested in RF. Items assessed demographics, familiarity with AI, clinical attitudes, and perceived barriers to the use of AI. Descriptive analyses were performed; no hypothesis testing was undertaken.
Results
Of 134 respondents, 60.4% were endocrinologists and 74.6% were senior consultants. While 62.7% had received Ramadan-specific diabetes training, only 23.9% had training in AI. Familiarity was highest with continuous glucose monitoring tools (55.2%) and automated insulin delivery systems (35.1%), yet 38.8% reported no knowledge of AI applications. Although 73.9% agreed AI could enhance safety during fasting, only 48.5% felt confident using AI for decision-making. Barriers included affordability (59.7%), limited access (56.0%), and lack of training (54.5%). Over a quarter of respondents perceived clinical benefits. Most respondents (69.4%) expressed interest in AI training.
Conclusion
Doctors recognize AI's potential to support safe fasting but face substantial knowledge and training gaps. Structured education, improved access, and culturally sensitive integration are urgently needed to enable wider adoption of AI in Ramadan-focused diabetes care.
Keywords
artificial intelligence - diabetes mellitus - Ramadan fasting - physician attitudes - continuous glucose monitoring - clinical practiceAuthor's Contribution
Single author.
Compliance with Ethical Principles
The study was deemed to carry no hazard to participants. No formal ethical approval was sought. However, consent for voluntary participation on an anonymous basis was secured electronically before participants could access the survey questions.
Data Availability Statement
All data supporting the study can be made available in a deidentified format upon a reasonable request to the corresponding author.
Publikationsverlauf
Artikel online veröffentlicht:
21. November 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Beshyah SA. Fasting during Ramadan for people with diabetes: medicine and Fiqh united at last. Ibnosina J Med Biomed Sci 2009; 1 (02) 58-60
- 2 Afandi B, Kaplan W, Al Kuwaiti F, Al Dahmani K, Nagelkerke N. Ramadan challenges: fasting against medical advice. J Nutr Fast Health 2017; 5 (03) 133-137
- 3 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 4 Karalis VD. The integration of artificial intelligence into clinical practice. Appl Biosci (Basel) 2024; 3 (01) 14-44
- 5 Sheng B, Pushpanathan K, Guan Z. et al. Artificial intelligence for diabetes care: current and future prospects. Lancet Diabetes Endocrinol 2024; 12 (08) 569-595
- 6 Mackenzie SC, Sainsbury CAR, Wake DJ. Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges. Diabetologia 2024; 67 (02) 223-235
- 7 Elhadd T, Mall R, Bashir M. et al; for PROFAST-Ramadan Study Group. Artificial intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during Ramadan (The PROFAST - IT Ramadan study). Diabetes Res Clin Pract 2020; 169: 108388
- 8 Al-Sofiani ME, Alharthi S, Albunyan S, Alzaman N, Klonoff DC, Alguwaihes A. A real-world prospective study of the effectiveness and safety of automated insulin delivery compared with other modalities of type 1 diabetes treatment during Ramadan intermittent fasting. Diabetes Care 2024; 47 (04) 683-691
- 9 Elbarbary NS, Ismail EAR. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed-loop system: a randomized controlled trial. Diabetes Res Clin Pract 2022; 191: 110045
- 10 Al-Sofiani ME, Petrovski G, Al Shaikh A. et al. The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: lessons from real world users during Ramadan. Diabetes Obes Metab 2024; 26 (03) 937-949
- 11 Wannes S, Gamal GM, Fredj MB. et al. Glucose control during Ramadan in a pediatric cohort with type 1 diabetes on MiniMed standard and advanced hybrid closed-loop systems: a pilot study. Diabetes Res Clin Pract 2023; 203: 110867
- 12 Zainudin SB, Hussain AB. The current state of knowledge, perception and practice in diabetes management during fasting in Ramadan by healthcare professionals. Diabetes Metab Syndr 2018; 12 (03) 337-342
- 13 Liao J, Wang T, Li Z, Xie H, Wang S. Experiences and views of people with diabetes during Ramadan fasting: a qualitative meta-synthesis. PLoS One 2020; 15 (11) e0242111
- 14 Beshyah SA. Artificial intelligence for diabetes care during Ramadan fasting: a narrative review. J Diab Endocrine Pract 2025;
- 15 Dwivedi R, Cipolle C, Hoefer C. Development and assessment of an interprofessional curriculum for managing diabetes during Ramadan. Am J Pharm Educ 2018; 82 (07) 6550
- 16 Lum ZK, See Toh WY, Lim SM. et al. Development of a collaborative algorithm for the management of type 2 diabetes during Ramadan: an anchor on empowerment. Diabetes Technol Ther 2018; 20 (10) 698-703
